Home Tags Regeneron Pharmaceuticals

Tag: Regeneron Pharmaceuticals

First biologic medicine approved for adults with moderate-to-severe atopic dermatitis

Phase 2 top-line Dupilumab results in chronic sinusitis with nasal polyps

Cristiana Bernini -

Newsstand

  • Supplement to n.5 - October 2025 NCF International n.2 - 2025
  • NCF International n.1 - 2025
  • Supplemento to n.9 - October 2024 NCF International n.3 - 2024
Newsstand
© © 2026 Tecniche Nuove Spa - All rights reserved. Registered office: Via Eritrea 21 - 20157 Milan. Share capital: 5,000,000 Euro fully paid up. Tax code, VAT number and registration with the Milan Register of Companies: 00753480151